Targeting stat3-vista axis to suppress tumor aggression and burden in acute myeloid leukemia

HIGHLIGHTS

• who: Jianshan Mo from the Increasepharm (Hengqin) Innovative Medicine Institute Limited, Zhuhai, China , Department of Medicine, Division of Hematologyu2011Oncology, and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA , State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China , Department of Hematology, Institute of Hematology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China have published the Article: Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia, in the Journal: (JOURNAL)
• how: Above results indicated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.